Description: Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.
Home Page: www.ankebio.com
AnkeBio Building
Hefei,
230088
China
Phone:
86 551 6531 9890
Officers
Name | Title |
---|---|
Mr. Lihua Song | Chairman of Board of Directors and Pres |
Mr. Yong Bin Wang | Financial Director |
Mr. Jian Ping Yao | Sr. VP |
Ms. She Wu Song | VP & Director |
Mr. Hai Sheng | Sr. VP |
Mr. Yong Biao Fu | VP & Director |
Mr. Xin Wen Yan | Deputy Gen. Mang. |
Ms. Hui Zhao | VP & Director |
Mr. Xing Li | Sec. of the Board |
Ms. Chunyan Lu | VP |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 48.3043 |
Price-to-Book MRQ: | 5.6711 |
Price-to-Sales TTM: | 7.5827 |
IPO Date: | 2009-10-30 |
Fiscal Year End: | December |
Full Time Employees: | 0 |